Silverman, H. J., & Dreyfuss, D. (2015). Were There “Additional Foreseeable Risks” in the SUPPORT Study? Lessons Not Learned from the ARDSnet Clinical Trials. The Hastings Center report, 45(1), 21-29. doi:10.1002/hast.403
Chicago Style (17th ed.) CitationSilverman, Henry J., and Didier Dreyfuss. "Were There “Additional Foreseeable Risks” in the SUPPORT Study? Lessons Not Learned from the ARDSnet Clinical Trials." The Hastings Center Report 45, no. 1 (2015): 21-29, https://doi.org/10.1002/hast.403.
MLA (9th ed.) CitationSilverman, Henry J., and Didier Dreyfuss. "Were There “Additional Foreseeable Risks” in the SUPPORT Study? Lessons Not Learned from the ARDSnet Clinical Trials." The Hastings Center Report, vol. 45, no. 1, 2015, pp. 21-29, https://doi.org/10.1002/hast.403.